NEW YORK, Dec. 13, 2021 /PRNewswire/ — The female infertility drugs market is expected to be dominated by North America, with the region accounting for 35% of the market’s growth during the forecast period. The US and Canada are the key countries for the female infertility drugs market in North America. However, the growth rate of the market in the region will be slower than the growth of the market in Asia and Europe. The rising prevalence of female infertility, adverse outcomes, and the high cost of non-therapeutic treatments will drive the growth of the female infertility drugs market in North America during the forecast period.
Attractive Opportunities in Female Infertility Drugs Market by Route of Administration and Geography – Forecast and Analysis 2021-2025 | State
April 2, 2022